Inhibitors of CTLA-4 and PD-1 induce MG, at times in apparent isolation but frequently in association with myositis, which also occurs in thymoma-associated MG but is otherwise not seen in early- or late-onset MG. This evidence concerns the gene CTLA4 and myasthenia gravis.